Behind the Bell: YS Biopharma
YS Biopharma President & CEO David Shao speaks to the company’s 21 year long history and what innovations $YS aims to bring to society as a #NasdaqListed company.
Source: Nasdaq
Related Articles
IAMGOLD Reports Fourth Quarter and Year-End 2022 Results
Share All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario–(Newsfile Corp. – February 16, 2023) – IAMGOLD Corporation (NYSE: IAG) (TSX:…
Mentech Innovations “Go Outside Together” the First Outdoor Ecosystem Summit Successfully Held
Share Shenzhen, China–(Newsfile Corp. – December 26, 2022) – On December 26th, 2022, the first outdoor Ecosystem Summit of Mentech Innovations 2022 with the theme…
Canadian Natural Resources Limited Announces 2022 Fourth Quarter and Year End Results
Share Calgary, Alberta–(Newsfile Corp. – March 2, 2023) – Canadian Natural’s (TSX: CNQ) (NYSE: CNQ) President, Tim McKay, commented on the Company’s 2022 results, “In 2022,…
Responses